Dermatofibroma laboratory findings: Difference between revisions

	Dermatofibroma Microchapters
Home
Patient Information
Overview
Historical Perspective
Classification
Pathophysiology
Causes
Differentiating Dermatofibroma from other Diseases
Epidemiology and Demographics
Risk Factors
Screening
Natural History, Complications and Prognosis
Diagnosis
Diagnostic Study of Choice
History and Symptoms
Physical Examination
Laboratory Findings
Electrocardiogram
Chest X Ray
CT
MRI
Echocardiography or Ultrasound
Other Imaging Findings
Other Diagnostic Studies
Treatment
Medical Therapy
Interventions
Surgery
Primary Prevention
Secondary Prevention
Cost-Effectiveness of Therapy
Future or Investigational Therapies
Case Studies
Case #1
Dermatofibroma laboratory findings On the Web
Most recent articles
Most cited articles
Review articles
CME Programs
Powerpoint slides
Images
American Roentgen Ray Society Images of Dermatofibroma laboratory findings All Images X-rays Echo & Ultrasound CT Images MRI
Ongoing Trials at Clinical Trials.gov
US National Guidelines Clearinghouse
NICE Guidance
FDA on Dermatofibroma laboratory findings
CDC on Dermatofibroma laboratory findings
Dermatofibroma laboratory findings in the news
Blogs on Dermatofibroma laboratory findings
Directions to Hospitals Treating Type page name here
Risk calculators and risk factors for Dermatofibroma laboratory findings

VisualWikitext

Revision as of 13:20, 30 July 2019

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1], Associate Editor(s)-in-Chief: Homa Najafi, M.D.[2]

Overview

There are no diagnostic laboratory findings associated with dermatofibroma.

Laboratory Findings

There are no diagnostic laboratory findings associated with dermatofibroma.

References

@@ Line 3: / Line 3: @@
 {{CMG}}, {{AE}}{{Homa}}
 ==Overview==
-An elevated/reduced concentration of serum/blood/urinary/CSF/other [lab test] is diagnostic of [disease name].
+There are no diagnostic laboratory findings associated with dermatofibroma.
-OR
-Laboratory findings consistent with the diagnosis of [disease name] include [abnormal test 1], [abnormal test 2], and [abnormal test 3].
-OR
-[Test] is usually normal for patients with [disease name].
-OR
-Some patients with [disease name] may have elevated/reduced concentration of [test], which is usually suggestive of [progression/complication].
-OR
-There are no diagnostic laboratory findings associated with [disease name].
 ==Laboratory Findings==
-There are no diagnostic laboratory findings associated with [disease name].
+There are no diagnostic laboratory findings associated with dermatofibroma.
-OR
-An elevated/reduced concentration of serum/blood/urinary/CSF/other [lab test] is diagnostic of [disease name].
-OR
-[Test] is usually normal among patients with [disease name].
-OR
-Laboratory findings consistent with the diagnosis of [disease name] include:
-*[Abnormal test 1]
-*[Abnormal test 2]
-*[Abnormal test 3]
-OR
-Some patients with [disease name] may have elevated/reduced concentration of [test], which is usually suggestive of [progression/complication].
 ==References==
@@ Line 50: / Line 15: @@
 [[Category:Medicine]]
 [[Category:Oncology]]
 [[Category:Up-To-Date]]
 [[Category:Primary care]]
 [[Category:Dermatology]]

Dermatofibroma laboratory findings: Difference between revisions

Revision as of 13:20, 30 July 2019

Overview

Laboratory Findings

References

Navigation menu